Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60.

scientific article published on February 2002

Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/107999002753536248
P698PubMed publication ID11911810

P2093author name stringBetty Lamothe
Bharat B Aggarwal
P433issue2
P921main subjectleukemiaQ29496
P304page(s)269-279
P577publication date2002-02-01
P1433published inJournal of Interferon and Cytokine ResearchQ15754749
P1476titleEctopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60.
P478volume22

Reverse relations

cites work (P2860)
Q39392672AW00179 potentiates TRAIL-mediated death of human lung cancer H1299 cells through ROS-JNK-c-Jun-mediated up-regulation of DR5 and down-regulation of anti-apoptotic molecules
Q40388128Agonists of an ecdysone-inducible mammalian expression system inhibit Fas Ligand- and TRAIL-induced apoptosis in the human colon carcinoma cell line RKO.
Q43673692Analysis of TNF-related apoptosis-inducing ligand in vivo through bone marrow transduction and transplantation
Q28176737Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy
Q80362724CDK11(p58) protein kinase activity is associated with Bcl-2 down-regulation in pro-apoptosis pathway
Q35198905Caspase-mediated cell death in hematological malignancies: theoretical considerations, methods of assessment, and clinical implications
Q40431685Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells
Q44319730Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation
Q40518043Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Q40553526Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis.
Q38997397Efficient Engraftment of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells in uPA/SCID Mice by Overexpression of FNK, a Bcl-xL Mutant Gene.
Q40587921Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
Q42176172Ethanolic extract of Thevetia peruviana flowers enhances TNF-α and TRAIL-induced apoptosis of human cervical cancer cells via intrinsic and extrinsic pathways
Q37729281Homoharringtonine acts synergistically with SG235-TRAIL, a conditionally replicating adenovirus, in human leukemia cell lines
Q30881749Localization of TRAIL/TRAILR in fetal pancreas
Q40094198Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization.
Q40846156Modulation of neutrophil apoptosis by antimicrobial peptides
Q39594325NSP 5a3a: a potential novel cancer target in head and neck carcinoma
Q34072314Overcoming hypoxic-resistance of tumor cells to TRAIL-induced apoptosis through melatonin
Q35756929Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors
Q24683245Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand
Q33855963Synthetic glycosidated phospholipids induce apoptosis through activation of FADD, caspase-8 and the mitochondrial death pathway
Q39263297TRAIL-NP hybrids for cancer therapy: a review.
Q36392814Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist
Q34139621Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo.

Search more.